After years of relying on 5FU, colorectal cancer clinicians now have a wealth of targeted therapies and combination protocols to choose from. The question is, what to use in which patients and when?
Related Articles
Focus
Angiogenesis inhibition: do tumours have a plan B?
Senza categoria
N E W S R O U N D
Senza categoria
Leave a Reply